Ross Products
This article was originally published in The Tan Sheet
Executive Summary
Similac and Ensure marketer's U.S. sales up 1% to $493 mil. in Q4 and 4% to $2.03 bil. for the year. Abbott Labs division reports growth in pediatric nutritionals continues to be driven by new products, line extensions and innovative packaging; Ross recently began rolling out to selected markets Isomil Soy Formula with Iron in "ready-to-feed" aseptic bottles and also launched Similac 2 with Iron in infant and toddler formulas. Abbott's overall fourth quarter net sales increased 6.8% to $3.7 bil. as net earnings jumped 13.5% to $753.4 mil. For the year, net sales reached $13.75 bil., up 4.3%, and net earnings saw a 13.9% spike to $2.79 bil
You may also be interested in...
Coupon Accounting Adjustment Revenue Impact Cited To Analysts
Pharmaceutical and consumer product firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.
Coupon Accounting Adjustment Revenue Impact Cited To Analysts
Pharmaceutical and consumer product firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.
Coupon Accounting Adjustment Revenue Impact Cited To Analysts
Pharmaceutical and consumer product firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.